Tony Nguyen

Tony Nguyen is a Research Analyst at RTW Investments, LLC in New York, where he leads commercial analysis of biopharmaceutical and medical technology assets within the firm. He plays a pivotal role as the founding member of RTW's internal Valuation Committee, ensuring scientific rigor and the commercial viability of next-generation drugs and technologies.

Tony specializes in evaluating assets in the biopharma and medical technology sectors, focusing on products at the intersection of genetic disease research and innovative therapies. His analysis directly supports RTW's investments across the full lifecycle—from early academic projects to publicly traded companies—with special attention to breakthrough drugs and medical technologies poised to impact patient lives.

He brings a strong academic background, holding a BS in Electrical Engineering from the National University of Singapore and an MBA in Finance from St. John's University, both earned on full academic scholarship. Tony's analytical expertise and leadership are reflected in his contributions to the successful commercialization of multiple drugs and technologies in RTW's portfolio, solidifying his reputation as an influential figure in life sciences investing.